Ligands for prevention of neurotoxicity of the alzheimer's disease related amyloid-beta peptide
申请人:AlphaBeta AB
公开号:US10023610B2
公开(公告)日:2018-07-17
The present invention relates to the field of molecular biochemistry and medicine, and in particular to ligands comprising modified amino acid residues, targeting the amyloid-β peptide associated with Alzheimer's disease for prevention of aggregation, neurotoxicity and use thereof as drugs for treatment of Alzheimer's disease.
本发明涉及分子生物化学和医学领域,特别是涉及由修饰氨基酸残基组成的配体,其靶标是与阿尔茨海默氏症相关的淀粉样蛋白-β肽,用于预防聚集、神经毒性以及将其用作治疗阿尔茨海默氏症的药物。